Variant report
Variant | esv5922 |
---|---|
Chromosome Location | chr4:131694728-131695207 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374567192 | chr4:131694761-131694762 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561233115 | chr4:131694763-131694764 | Enhancers Weak transcription Transcr. at gene 5' and 3' | n/a | n/a | Overlapped CNVs | n/a |
3 | rs377469607 | chr4:131694838-131694839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201424449 | chr4:131694839-131694840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs199550976 | chr4:131694840-131694841 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547059021 | chr4:131694848-131694849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571613681 | chr4:131694855-131694856 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113064499 | chr4:131694865-131694866 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200680145 | chr4:131694876-131694877 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs180984284 | chr4:131694907-131694908 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184896497 | chr4:131694909-131694910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532334720 | chr4:131694920-131694921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543878625 | chr4:131694930-131694931 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190144771 | chr4:131694944-131694945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181166646 | chr4:131695020-131695021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201513023 | chr4:131695021-131695022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200081367 | chr4:131695023-131695024 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs200697495 | chr4:131695029-131695030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535037744 | chr4:131695058-131695059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs70944271 | chr4:131695059-131695060 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111278131 | chr4:131695074-131695075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs397995401 | chr4:131695076-131695077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12505519 | chr4:131695089-131695090 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs566268164 | chr4:131695172-131695173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555937081 | chr4:131695176-131695177 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs3103397 | chr4:131695202-131695203 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:131689800-131697400 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr4:131690000-131698400 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr4:131693200-131695600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr4:131694400-131694800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr4:131694400-131694800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:131694400-131694800 | Transcr. at gene 5' and 3' | iPS-18 Cell Line | embryonic stem cell |
7 | chr4:131694400-131694800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr4:131694400-131695400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr4:131694400-131695400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr4:131694400-131695800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr4:131694800-131695600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr4:131694800-131695600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |